Single User License
INR 8428
Site License
INR 16855
Corporate User License
INR 25283

Service Tax Additional

select a format
Price

Single User License
USD 125
Site License
USD 250
Corporate User License
USD 375

Alternatively

Request a quote
Request a Customized research
Request for Sample Report





Recent Viewed Reports


Why Ken Reasearch?


Testimonials

While we still are studying and analysing your reports about Vietnam & Thailand, we would like to convey to your research team that they have done a very good job in compiling so much of information together. We hope to see more of such well researched reports. All the best & keep it up. ... "Prashant Bhagwat,General Manager, Mahindra"

We would like to appreciate Ken Research for their great efforts and wonderful support in providing the Market Intelligence Report for ITPC. The information, statistics and research are well understandable and very clear to the point. We are happy with Ken research for their good client service, on-time delivery of the report and as said the report itself. Thank you Ken research for bringing the valuable output for us. We would be looking forward to have more research with you in the near future. Wish you a success in your business!... "Jestin Mathew, Indonesian Trade Promotion Center"

The Report was very interesting and useful for me... "Marketing Manager, Western Union Business Solutions"

Ken Research completed the report successfully with tough deadline and large requirement. Really appreciate it... "Sales Manager, Largest India Aesthetic Laser Manufacturer"

We found the report really useful in understanding the complex Indian market and it provided lots of high quality insights. On the basis of this we commissioned Ken to produce a bespoke follow up to answer some specific questions about our market. This is now being used to help develop our marketing and sales strategy. We were very pleased with the comprehensive coverage, detail provided and actionable insights.... "Owner, Therefore Consulting UK"


Benitec Biopharma Limited (BLT)-Financial and Strategic SWOT Analysis Review

Benitec Biopharma Limited (BLT)-Financial and Strategic SWOT Analysis Review


  Request for Sample Report

Executive Summary

Benitec Biopharma Limited (BLT)-Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company's businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company's key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

The profile contains critical company information including:

Business description-A detailed description of the company's operations and business divisions.

Corporate strategy-Analyst's summarization of the company's business strategy.

SWOT Analysis-A detailed analysis of the company's strengths, weakness, opportunities and threats.

Company history-Progression of key events associated with the company.

Major products and services-A list of major products, services and brands of the company.

Key competitors-A list of key competitors to the company.

Key employees-A list of the key executives of the company.

Executive biographies-A brief summary of the executives' employment history.

Key operational heads-A list of personnel heading key departments/functions.

Important locations and subsidiaries-A list and contact details of key locations and subsidiaries of the company.

Key manufacturing facilities-A list of key manufacturing facilities of the company.

Detailed financial ratios for the past five years-The latest financial ratios derived from the annual financial statements published by the company with 5 years history.

Interim ratios for the last five interim periods-The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Highlights

Benitec Biopharma Limited (Benitec), is a research based clinical stage biotechnology company. The company develops novel therapeutics for the treatment of chronic and life threatening diseases based on its proprietary gene silencing DNA directed RNA interference (ddRNAi) technology. It develops g ddRNAi based therapeutics for various conditions such as hepatitis B, wet age related macular degeneration and OPMD. The company also licenses its ddRNAi to various biopharmaceutical companies for the development of drugs for the treatment of conditions such as HIV/AIDS, Huntington's disease, chronic neuropathic pain, cancer immunotherapy and retinitis. The company has its research laboratories in Hayward, California, the US. Benitec is headquartered in Sydney, New South Wales, Australia.

Benitec Biopharma Limited Key Recent Developments

Aug 16, 2016: Benitec Announces Appointment Of New Director And Chair Of Audit Committee And Retirement Of Director, Mr Iain Ross

Aug 10, 2016: Benitec announces restructuring of Senior Executive team

Jun 16, 2016: Benite Biopharma: Federal R&D Tax Credit Received

May 24, 2016: Benitec Biopharma Interim Report for the Nine Months Ended March 31, 2016

Apr 29, 2016: Benitec Biopharma: Quarterly Cash FlowAppendix 4C

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.

The profile analyzes the company's business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors' business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.

The company's core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.

Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies' strategic, financial and operational performance.

Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.

Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company

Table of Contents

Table of Contents 2

List of Tables 4

List of Figures 5

Section 1-About the Company 6

Benitec Biopharma Limited-Key Facts 6

Benitec Biopharma Limited-Key Employees 7

Benitec Biopharma Limited-Key Employee Biographies 8

Benitec Biopharma Limited-Major Products and Services 9

Benitec Biopharma Limited-Pharmaceutical Pipeline Products Data 10

Benitec Biopharma Limited, Pipeline Products by Therapy Area 10

Benitec Biopharma Limited, Pipeline Products by Development Phase 11

Benitec Biopharma Limited-History 13

Benitec Biopharma Limited-Locations And Subsidiaries 17

Head Office 17

Other Locations & Subsidiaries 17

Section 2-Company Analysis 18

Benitec Biopharma Limited-Business Description 18

Benitec Biopharma Limited-Corporate Strategy 19

Benitec Biopharma Limited-SWOT Analysis 20

SWOT Analysis-Overview 20

Benitec Biopharma Limited-Strengths 20

Strength-Licensing Partnerships 20

Strength-Proprietary Technology 20

Strength-Strong Patent Position 20

Benitec Biopharma Limited-Weaknesses 21

Weakness-History of Losses 21

Benitec Biopharma Limited-Opportunities 22

Opportunity-Market Potential: RNA interference 22

Opportunity-Growth Prospects: Oncology 22

Opportunity-Strategic Acquisition 22

Benitec Biopharma Limited-Threats 23

Threat-Industry Regulations 23

Threat-Highly Competitive Industry 23

Threat-Uncertain R&D Outcomes 23

Benitec Biopharma Limited-Key Competitors 24

Section 3-Company Financial Ratios 25

Financial Ratios-Capital Market Ratios 25

Financial Ratios-Annual Ratios 26

Performance Chart 27

Financial Performance 27

Financial Ratios-Interim Ratios 28

Financial Ratios-Ratio Charts 29

Section 4-Company's Lifesciences Financial Deals and Alliances 30

Benitec Biopharma Limited, Pharmaceuticals & Healthcare, Deals By Year, 2010 to YTD 2016 30

Benitec Biopharma Limited, Pharmaceuticals & Healthcare, Deals By Type, 2010 to YTD 2016 31

Benitec Biopharma Limited, Recent Deals Summary 32

Section 5-Company's Recent Developments 33

Aug 16, 2016: Benitec Announces Appointment Of New Director And Chair Of Audit Committee And Retirement Of Director, Mr Iain Ross 33

Aug 10, 2016: Benitec announces restructuring of Senior Executive team 34

Jun 16, 2016: Benite Biopharma: Federal R&D Tax Credit Received 35

May 24, 2016: Benitec Biopharma Interim Report for the Nine Months Ended March 31, 2016 36

Apr 29, 2016: Benitec Biopharma: Quarterly Cash FlowAppendix 4C 37

Apr 06, 2016: CSHL Reports That the U.S. Patent Office Denies All 4 Petitions Filed by Benitec Biopharma against CSHL's shRNA Patents 38

Feb 26, 2016: Benitec Biopharma : Interim Report for the Half Year Ended December 31, 2015 39

Dec 08, 2015: Greg West, Benitec's Chief Financial Officer and Company Secretary, Named Interim Chief Executive Officer 40

Oct 19, 2015: Benitec Forms Hepatology Clinical Advisory 41

Oct 19, 2015: Benitec Forms Hepatology Clinical Advisory Board 42

Section 6-Appendix 43

Methodology 43

Ratio Definitions 43

About GlobalData 47

Contact Us 47

Disclaimer 47

List of Figures

Benitec Biopharma Limited, Pipeline Products by Therapy Area 10

Benitec Biopharma Limited, Pipeline Products by Development Phase 11

Benitec Biopharma Limited, Performance Chart (2011-2015) 27

Benitec Biopharma Limited, Ratio Charts 29

Benitec Biopharma Limited, Pharmaceuticals & Healthcare, Deals By Year, 2010 to YTD 2016 30

Benitec Biopharma Limited, Pharmaceuticals & Healthcare, Deals by Type, 2010 to YTD 2016 31

List of Tables

Benitec Biopharma Limited, Key Facts 6

Benitec Biopharma Limited, Key Employees 7

Benitec Biopharma Limited, Key Employee Biographies 8

Benitec Biopharma Limited, Major Products and Services 9

Benitec Biopharma Limited, Number of Pipeline Products by Therapy Area 10

Benitec Biopharma Limited, Number of Pipeline Products by Development Stage 11

Benitec Biopharma Limited, Pipeline Products By Therapy Area and Development Phase 12

Benitec Biopharma Limited, History 13

Benitec Biopharma Limited, Other Locations 17

Benitec Biopharma Limited, Subsidiaries 17

Benitec Biopharma Limited, Key Competitors 24

Benitec Biopharma Limited, Ratios based on current share price 25

Benitec Biopharma Limited, Annual Ratios 26

Benitec Biopharma Limited, Interim Ratios 28

Benitec Biopharma Limited, Pharmaceuticals & Healthcare, Deals By Year, 2010 to YTD 2016 30

Benitec Biopharma Limited, Pharmaceuticals & Healthcare, Deals By Type, 2010 to YTD 2016 31

Benitec Biopharma Limited, Recent Deals Summary 32

Currency Codes 43

Capital Market Ratios 43

Equity Ratios 44

Profitability Ratios 44

Cost Ratios 45

Liquidity Ratios 45

Leverage Ratios 46

Efficiency Ratios 46

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License:
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

To know more information on Purchase by Section, please send a mail to query [@] kenresearch.com
 

Silence Therapeutics Plc

Quark Pharmaceuticals, Inc.

MyoKardia, Inc.

Arrowhead Pharmaceuticals, Inc.

Arcturus Therapeutics, Inc.

Arbutus Biopharma Corporation

Alnylam Pharmaceuticals, Inc.

Benitec Biopharma Limited, SWOT analysis, SWOT, Strengths, Weaknesses, Opportunities, Threats, Corporate Strategy, Key Ratios, Share Data, Performance, Financial Performance, Overview, Business Description, Major Product, Brands, History,Key Employees, Key Operational Heads, Strategy, Key Competitors, Company Statement, Capital Market Ratios, Financial Ratios, Annual Ratios, Interim Ratios, Ratio Charts


Related Products in vertical
Ken Research Pvt. Ltd. 27A, Tower B-2, Spaze I Tech Business Park, Sohna Road, sector 49
     Gurgaon, Haryana - 122001, India
+91 1244230204

download

Company Brochure

Engage with Us

query [@] kenresearch.com